Carl Zeiss Meditec AG (CZMWF)
OTCMKTS · Delayed Price · Currency is USD
50.31
+0.82 (1.66%)
Sep 11, 2025, 1:26 PM EDT
Carl Zeiss Meditec AG Market Cap
Carl Zeiss Meditec AG has a market cap or net worth of $4.38 billion as of September 12, 2025. Its market cap has decreased by -31.68% in one year.
Market Cap
4.38B
Enterprise Value
5.07B
Revenue
2.56B
Ranking
n/a
PE Ratio
24.87
Stock Price
$50.31
Market Cap Chart
Since July 30, 2002, Carl Zeiss Meditec AG's market cap has increased from 277.97M to 4.38B, an increase of 1,477.33%. That is a compound annual growth rate of 12.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 4.38B | 6.05% |
| Dec 30, 2024 | 4.13B | -57.69% |
| Dec 29, 2023 | 9.77B | -13.29% |
| Dec 30, 2022 | 11.27B | -39.80% |
| Dec 30, 2021 | 18.72B | 56.40% |
| Dec 30, 2020 | 11.97B | 4.92% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Elite Pharmaceuticals | 750.21M |
| Tian'an Technology Group | 723.74M |
| Glass House Brands | 566.73M |
| Northwest Biotherapeutics | 390.10M |
| CytoDyn | 358.38M |
| American Oncology Network | 353.52M |